4.6 Article

Sigma-1 receptors are essential for capsaicin-induced mechanical hypersensitivity: Studies with selective sigma-1 ligands and sigma-1 knockout mice

Journal

PAIN
Volume 143, Issue 3, Pages 252-261

Publisher

LIPPINCOTT WILLIAMS & WILKINS
DOI: 10.1016/j.pain.2009.03.011

Keywords

Sigma-1 receptors; Capsaicin; Mechanical allodynia; Hyperalgesia; Pain behavior; Knockout mice

Funding

  1. Formacion de Profesorado Universitario grants (M.E.C.)
  2. Research Program of the University of Granada
  3. junta de Andalucia [CTS 109]
  4. Spanish Ministerio de Educacion y Ciencia (MEC) [SAF 2006-06122]
  5. FEDER funds
  6. Laboratorios Dr. Esteve S.A.
  7. Centro para el Desarrollo Tecnologico Industrial

Ask authors/readers for more resources

We evaluated the role of sigma(1) receptors on capsaicin-induced mechanical hypersensitivity and on nociceptive pain induced by punctate mechanical stimuli, using wild-type and sigma(1) receptor knockout (sigma(1)-KO) mice and selective sigma(1) receptor-acting drugs. Mutation in sigma(1)-KO mice was confirmed by PCR analysis of genomic DNA and, at the protein level, by [H-3](+)-pentazocine binding assays. Both wild-type and sigma(1)-KO mice not treated with capsaicin showed similar responses to different intensities of mechanical stimuli (0.05-8 g force), ranging from innocuous to noxious, applied to the hind paw. This indicates that sigma(1) gene inactivation does not modify the perception of punctate mechanical stimuli. The intraplantar (i.pl.) administration of capsaicin induced dose-dependent mechanical allodynia in wild-type mice (markedly reducing both the threshold force necessary to induce paw withdrawal and the latency to paw withdrawal induced by a given force). In contrast, capsaicin was completely unable to induce mechanical hypersensitivity in sigma(1)-KO mice. The high-affinity and selective sigma(1) antagonists BD-1063, BD-1047 and NE-100, administered subcutaneously (s.c.), dose-dependently inhibited mechanical allodynia induced by capsaicin (1 mu g,i.pl.), yielding ED50 (mg/kg) values of 15.80 +/- 0.93, 29.31 +/- 1.65 and 40.74 +/- 7.20, respectively. The effects of the sigma(1) antagonists were reversed by the sigma(1) agonist PRE-084 (32 mg/kg, s.c.). None of the drugs tested modified the responses induced by a painful mechanical punctate stimulus (4 g force) in nonsensitized animals. These results suggest that sigma(1) receptors are essential for capsaicin-induced mechanical hypersensitivity, but are not involved in mechanical nociceptive pain. (C) 2009 International Association for the Study of Pain. Published by Elsevier B.V. All rights reserved.

Authors

I am an author on this paper
Click your name to claim this paper and add it to your profile.

Reviews

Primary Rating

4.6
Not enough ratings

Secondary Ratings

Novelty
-
Significance
-
Scientific rigor
-
Rate this paper

Recommended

Article Biochemistry & Molecular Biology

From binge eating to binge drinking: A new and robust paradigm for assessing binge ethanol self-administration in male rats

Leandro Ruiz-Leyva, Ana Vazquez-Agredos, Ana M. Jimenez-Garcia, Olga Lopez-Guarnido, Antonio Pla, Ricardo Marcos Pautassi, Ignacio Moron Henche, Cruz Miguel Cendan

Summary: The present study validates a novel model of voluntary ethanol consumption in male Wistar rats, in which ethanol access follows binge eating, and demonstrates a significant increase in ethanol consumption after binge eating compared to control eating. This model shows remarkable potential for research on different stages of alcohol addiction and assessing interactions between alcohol consumption and other addictive-like behaviors.

ADDICTION BIOLOGY (2022)

Article Chemistry, Medicinal

Synthesis of tropane-based σ1 receptor antagonists with antiallodynic activity

Elena Bechthold, Julian A. Schreiber, Nadine Ritter, Lucie Grey, Dirk Schepmann, Constantin Daniliuc, Rafael Gonzalez-Cano, Francisco Rafael Nieto, Guiscard Seebohm, Bernhard Wuensch

Summary: This study synthesized several high affinity sigma(1) ligands by replacing the piperidine ring and introducing a bicyclic tropane system. Two of these compounds showed high antiallodynic activity in vivo and exhibited high selectivity for the sigma(1) receptor.

EUROPEAN JOURNAL OF MEDICINAL CHEMISTRY (2022)

Article Neurosciences

Administration of the sigma-1 receptor agonist PRE-084 at emerging adulthood, but not at early adolescence, attenuated ethanol-induced conditioned taste aversion in female rats

Agustin Salguero, Leonardo Marengo, Enrique Portillo-Salido, Leandro Ruiz-Leyva, Cruz Miguel Cendan, Ignacio Moron Henche, Ricardo Marcos Pautassi

Summary: The study explored the effects of sigma-1 receptors (S1-R) activation on ethanol-induced conditioned taste aversion (CTA) in early adolescence and terminal adolescence/emerging adulthood in female Wistar rats. The results showed that S1-R activation attenuated the learning of ethanol-induced CTA at terminal adolescence but not at early adolescence. Additionally, S1-R activation did not significantly affect binge-like ethanol intake in terminal adolescents.

NEUROSCIENCE LETTERS (2022)

Article Clinical Neurology

Minocycline Prevents the Development of Key Features of Inflammation and Pain in DSS-induced Colitis in Mice

Teresa Vezza, Jose Alberto Molina-Tijeras, Rafael Gonzalez-Cano, Alba Rodriguez-Nogales, Federico Garcia, Julio Galvez, Enrique J. Cobos

Summary: Abdominal pain is a common symptom in patients with inflammatory bowel disease (IBD) and has a significant impact on their quality of life. Minocycline, a broad-spectrum tetracycline antibiotic, has been identified as a potential therapy for managing visceral pain in IBD-induced colitis in mice.

JOURNAL OF PAIN (2023)

Article Clinical Neurology

Small Synthetic Hyaluronan Disaccharide BIS014 Mitigates Neuropathic Pain in Mice

Juan-Fernando Padin, Marcos Maroto, Jose Manuel Entrena, Javier Egea, Eulalia Montell, Josep Verges, Manuela G. Lopez, Enrique J. Cobos, Antonio G. Garcia

Summary: A new sulfated disaccharide compound, BIS014, has been found to have analgesic effects and can alleviate various neuropathic pain conditions. Unlike existing drugs, BIS014 does not cause sedation and has the potential to become a new effective non-sedative oral medication for neuropathic pain treatment.

JOURNAL OF PAIN (2023)

Article Pharmacology & Pharmacy

The sigma-1 receptor curtails endogenous opioid analgesia during sensitization of TRPV1 nociceptors

M. Carmen Ruiz-Cantero, Elsa Cortes-Montero, Aakanksha Jain, Angeles Montilla-Garcia, Inmaculada Bravo-Caparros, Jaehoon Shim, Pilar Sanchez-Blazquez, Clifford J. Woolf, Jose M. Baeyens, Enrique J. Cobos

Summary: The sigma-1 receptor interacts with TRPV1 and the μ-opioid receptor, and antagonizing sigma-1 receptor can reduce PGE2- and NGF-induced hyperalgesia by increasing the activity of the μ-opioid receptor. This mechanism is not effective against GDNF-induced hyperalgesia. The sigma-1 antagonism transfers the sigma-1 receptor from TRPV1 to μ-opioid receptor and harnesses endogenous opioids produced by TRPV1+ neurons to reduce hyperalgesia.

BRITISH JOURNAL OF PHARMACOLOGY (2023)

Article Biochemistry & Molecular Biology

Synthesis, Computational Insights, and Evaluation of Novel Sigma Receptors Ligands

Maria Dichiara, Francesca Alessandra Ambrosio, Carla Barbaraci, Rafael Gonzalez-Cano, Giosue Costa, Carmela Parenti, Agostino Marrazzo, Lorella Pasquinucci, Enrique J. Cobos, Stefano Alcaro, Emanuele Amata

Summary: The development of diazabicyclo[4.3.0]nonane and 2,7-diazaspiro[3.5]nonane derivatives as sigma receptors (SRs) ligands is discussed. The compounds were evaluated for their binding to S1R and S2R, and modeling studies were conducted to analyze the binding mode. Three notable compounds, 4b, 5b, and 8f, were further tested for their analgesic effects and functional profiles. Compound 4b showed S1R agonistic effects, while compounds 5b and 8f exhibited S1R antagonism.

ACS CHEMICAL NEUROSCIENCE (2023)

Article Chemistry, Medicinal

Conformationally Restricted?1 Receptor Antagonists from (-)-Isopulegol

Luca Blicker, Rafael Gonzalez-Cano, Erik Laurini, Francisco R. Nieto, Judith Schmidt, Dirk Schepmann, Sabrina Pricl, Bernhard Wunsch

Summary: Antagonists targeting sigma 1 receptors show promise for neuropathic pain treatment. A series of aminodiols were synthesized from (-)-isopulegol (1) and transformed into bicyclic and tricyclic derivatives. The aminodiols exhibited higher sigma 1 affinity compared to the derivatives. The study also revealed the importance of stereochemistry and compound structure in modulating sigma 1 affinity.

JOURNAL OF MEDICINAL CHEMISTRY (2023)

Review Chemistry, Medicinal

Efficacy and Security of Tetrodotoxin in the Treatment of Cancer-Related Pain: Systematic Review and Meta-Analysis

Miguel A. Huerta, Javier de la Nava, Antonia Artacho-Cordon, Francisco R. Nieto

Summary: The current pharmacological treatment for cancer-related pain is not satisfactory. This study conducted a systematic review and meta-analysis to evaluate the clinical evidence of tetrodotoxin (TTX) in treating cancer-related pain. The results showed that TTX significantly increased the number of responders to treatment and the occurrence of non-severe adverse events.

MARINE DRUGS (2023)

Article Chemistry, Medicinal

Discovery of AD258 as a Sigma Receptor Ligand with Potent Antiallodynic Activity

Maria Dichiara, Francesca Alessandra Ambrosio, Sang Min Lee, M. Carmen Ruiz-Cantero, Jessica Lombino, Adriana Coricello, Giosue Costa, Dhara Shah, Giuliana Costanzo, Lorella Pasquinucci, Kyung No Son, Giuseppe Cosentino, Rafael Gonzalez-Cano, Agostino Marrazzo, Vinay Kumar Aakalu, Enrique J. Cobos, Stefano Alcaro, Emanuele Amata

Summary: This work focuses on the design and synthesis of 2,7-diazaspiro[4.4]nonane derivatives as potent sigma receptor (SR) ligands with analgesic activity. The affinities of the compounds at S1R and S2R were measured, and molecular modeling studies were conducted to investigate the binding characteristics. The most promising compound 9d (AD258) showed negligible in vitro cellular toxicity, high binding affinity to both SRs, and high potency in a capsaicin-induced allodynia model.

JOURNAL OF MEDICINAL CHEMISTRY (2023)

Article Chemistry, Medicinal

Dual Piperidine-Based Histamine H3 and Sigma-1 Receptor Ligands in the Treatment of Nociceptive and Neuropathic Pain

Katarzyna Szczepanska, Tadeusz Karcz, Maria Dichiara, Szczepan Mogilski, Justyna Kalinowska-Tluscik, Boguslaw Pilarski, Arkadiusz Leniak, Wojciech Pietrus, Sabina Podlewska, Katarzyna Popiolek-Barczyk, Laura J. Humphrys, M. Carmen Ruiz-Cantero, David Reiner-Link, Luisa Leitzbach, Dorota Lazewska, Steffen Pockes, Michal Gorka, Adam Zmyslowski, Thierry Calmels, Enrique J. Cobos, Agostino Marrazzo, Holger Stark, Andrzej J. Bojarski, Emanuele Amata, Katarzyna Kiec-Kononowicz

Summary: In search of new dual-acting histamine H-3/sigma-1 receptor ligands, a series of compounds were designed based on previously studied highly active in vivo ligands. An in-depth analysis was conducted on the protonation states of piperazine and piperidine derivatives in the compounds, due to the significant difference in affinity at sigma-1 receptors observed in closely related compounds. Three lead structures (3, 7, and 12) were selected for further biological evaluation, and compound 12 showed a broad spectrum of analgesic activity based on a novel molecular mechanism in both nociceptive and neuropathic pain models.

JOURNAL OF MEDICINAL CHEMISTRY (2023)

Article Chemistry, Medicinal

Conformationally Restricted?1 Receptor Antagonists from (-)-Isopulegol

Luca Blicker, Rafael Gonzalez-Cano, Erik Laurini, Francisco R. Nieto, Judith Schmidt, Dirk Schepmann, Sabrina Pricl, Bernhard Wuensch

Summary: Antagonists at a1 receptors have great potential for treating neuropathic pain. The study examined different compounds and found that amino-diols showed higher a1 affinity than bicyclic and tricyclic derivatives. The configuration and structure of the compounds also influenced their a1 affinity and selectivity. A specific compound, aminodiol 8b, demonstrated high a1 affinity, selectivity, and promising activity in pain relief.

JOURNAL OF MEDICINAL CHEMISTRY (2023)

Article Chemistry, Medicinal

Synthesis, In Vitro Profiling, and In Vivo Evaluation of Benzohomoadamantane-Based Ureas for Visceral Pain: A New Indication for Soluble Epoxide Hydrolase Inhibitors

Sandra Codony, Jose M. Entrena, Carla Calvo-Tusell, Beatrice Jora, Rafael Gonzalez-Cano, Silvia Osuna, Ruben Corpas, Christophe Morisseau, Belen Perez, Marta Barniol-Xicota, Christian Grinan-Ferre, Concepcion Perez, Maria Isabel Rodriguez-Franco, Anton L. Martinez, M. Isabel Loza, Merce Pallas, Steven H. L. Verhelst, Coral Sanfeliu, Ferran Feixas, Bruce D. Hammock, Jose Brea, Enrique J. Cobos, Santiago Vazquez

Summary: A new benzohomoadamantane-based sEH inhibitor has been developed to improve the drug metabolism and pharmacokinetics properties for pain-related disorders, showing anti-allodynic and analgesic effects in murine models of capsaicin-induced allodynia and cyclophosphamide-induced cystitis.

JOURNAL OF MEDICINAL CHEMISTRY (2022)

Article Pharmacology & Pharmacy

Evaluation of poly (lactic-co-glycolic acid) nanoparticles to improve the therapeutic efficacy of paclitaxel in breast cancer

Laura Cabeza, Mazen M. El-Hammadi, Raul Ortiz, Maria D. Cayero-Otero, Julia Jimenez-Lopez, Gloria Perazzoli, Lucia Martin-Banderas, Jose M. Baeyens, Consolacion Melguizo, Jose Prados

Summary: The study demonstrated that PTX-PLGA nanoparticles significantly reduced the IC50 of breast cancer cells to paclitaxel, showing higher antitumor activity in vivo. The nanoformulation preserved the mechanism of action of paclitaxel and increased its intracellular uptake.

BIOIMPACTS (2022)

No Data Available